Platelet-rich plasma in the treatment of alopecia areata after COVID-19 vaccination.
Study Design
- Jenis Studi
- Case Reports
- Populasi
- None
- Durasi
- 4 weeks
- Intervensi
- Platelet-rich plasma in the treatment of alopecia areata after COVID-19 vaccination. None
- Pembanding
- None
- Luaran Utama
- hair growth/density
- Arah Efek
- Neutral
- Risiko Bias
- High
Abstract
KEY CLINICAL MESSAGE: Alopecia areata may develop in patients after COVID-19 vaccination. Platelet-rich plasma (PRP) has an outstanding anti-inflammatory effect and could be an alternative treatment for alopecia patients who are refractory or intolerant to corticosteroids. ABSTRACT: A 34-year-old female with no systemic illness presented with non-scarring hair loss after the second COVID-19 vaccination shot 4 weeks ago. The hair loss worsened and progressed to severe alopecia areata. We started double-spin PRP therapy. Her hair recovered completely after six courses of PRP treatment.
TL;DR
Platelet‐rich plasma (PRP) has an outstanding anti‐inflammatory effect and could be an alternative treatment for alopecia patients who are refractory or intolerant to corticosteroids.
Used In Evidence Reviews
Similar Papers
Journal of cosmetic dermatology · 2021
Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics.
Stem cells translational medicine · 2015
The Effect of Platelet-Rich Plasma in Hair Regrowth: A Randomized Placebo-Controlled Trial.
Clinical reviews in allergy & immunology · 2021
Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management.
Cells · 2019
Advances in Regenerative Stem Cell Therapy in Androgenic Alopecia and Hair Loss: Wnt pathway, Growth-Factor, and Mesenchymal Stem Cell Signaling Impact Analysis on Cell Growth and Hair Follicle Development.
The British journal of dermatology · 2013
A randomized, double-blind, placebo- and active-controlled, half-head study to evaluate the effects of platelet-rich plasma on alopecia areata.
Journal of the European Academy of Dermatology and Venereology : JEADV · 2018